**Core Concept**
Acute intermittent porphyria (AIP) is a rare genetic disorder affecting the production of heme, a crucial component of hemoglobin and various enzymes. AIP is caused by mutations in the HMBS gene, leading to a deficiency of the enzyme hydroxymethylbilane synthase. This enzyme is essential for the conversion of uroporphyrinogen to coproporphyrinogen in the heme biosynthetic pathway.

**Why the Correct Answer is Right**
The correct answer is related to the mechanism of AIP. In AIP, the deficiency of hydroxymethylbilane synthase leads to an accumulation of uroporphyrinogen, which is then converted to porphobilinogen (PBG). PBG is then converted to delta-aminolevulinic acid (ALA), resulting in an increase in ALA levels. This increase in ALA levels is a hallmark of AIP and can be detected in the urine. The increased levels of ALA and PBG are toxic to the nervous system, causing symptoms such as abdominal pain, neuropathy, and psychiatric disturbances.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to AIP, as it does not describe the biochemical mechanism underlying the disorder.
* **Option B:** This option is incorrect because it does not accurately describe the enzyme deficiency in AIP. The correct enzyme deficiency is hydroxymethylbilane synthase, not porphobilinogen deaminase.
* **Option C:** This option is incorrect because it does not accurately describe the biochemical mechanism underlying AIP. The correct mechanism involves the accumulation of uroporphyrinogen and the subsequent increase in ALA levels.

**Clinical Pearl / High-Yield Fact**
AIP is often precipitated by factors that increase the demand for heme, such as hormonal changes during menstruation or pregnancy, and certain medications such as estrogens and barbiturates. Patients with AIP may also experience symptoms during periods of fasting or starvation.

**Correct Answer: B. Porphyria cutanea tarda is caused by a deficiency of uroporphyrinogen decarboxylase.**